Navigation Links
Genesis Pharmaceuticals Donates Medicine to China Sichuan Earthquake Relief
Date:5/16/2008

LAIYANG, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC) ("Genesis" or the "Company"), a leading pharmaceutical company in the People's Republic of China, today announced that it had donated medicines with a total value of RMB3.0 million (approximately US$428,000) to Sichuan Earthquake relief. These medicines were shipped to Sichuan on 8:00AM May 16, 2008 Beijing Time.

"We are extremely grieved to know that people lost their lives and their homes as a result of the earthquake on May 12, 2008. It has been reported that up to now at least twenty thousand people lost their lives. Many more were severely injured and their lives are threatened as a result of a shortage of medicine," said Mr. Wubo Cao, Chairman and Chief Executive Officer of Genesis. "We feel obligated to show our love and support to the rescue efforts. We hope more lives can be saved and the Sichuan people will be able to recover from the earthquake disaster earlier."

About Genesis Pharmaceuticals Enterprises, Inc.

Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Northeast China in an Economic Development Zone in Laiyang City, Shandong province. Genesis is a major pharmaceutical company in China producing tablets, capsules, and granules for both western and Chinese herbal-based medical drugs.

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-look
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. EURYI project to understand how the brain wires during embryogenesis
3. DNA damage response confers a barrier for viral tumorigenesis
4. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
5. The genetics of MLL leukemogenesis
6. Genesis Technology Group Retains CCG Elite
7. Researchers chart the genetic mechanisms behind the genesis of fat cells
8. Tissue Genesis Signs Exclusive Distribution and License Agreement with SpineSmith
9. ThermoGenesis Corp. Reports First Quarter 2008 Results
10. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
11. Genesis Pharmaceuticals Announces Results for The First Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... MONROVIA, Calif., July 24 /PRNewswire-FirstC... leading developer, manufacturer and marketer of,m...nced that the Centers,for Medicare and Medicaid Se...heric cataract lenses as New Technology Intraocula...amer(R) Aspheric Single Piece foldable,intraocular...
(Date:7/24/2008)... Ground-breaking Technology Debuts in the Trance... Shoe, BOTHELL, Wash., July 24 /PRNewswi...Sports, Inc. today announced that BioMoGo, the wor... to consumers in the new Trance(TM),8 premium supp... times,faster than conventional athletic shoe mids...
(Date:7/24/2008)... NEW YORK, July 24 /PRNewswire/ -- MS -- Toda...nt things. For those who care for their,bodies, by...ations for,anti-aging, it is possible to feel and ...http://www.newscom.com/cgi-bin/prnh/20080724/NYFNS...uthor, and frequent guest on,Oprah Winfrey,s progr...
(Date:7/24/2008)... SCHAUMBURG, Ill., July 24 /PRNewswire/ -- A ...America,s most chronic problems -- obesity -- in,p... weight problem. About one third of us are,obese, ...ets -- they really,do look like us -- mirror us wi...esity, a public/private partnership that includes,...
Breaking Medicine News(10 mins):Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 2Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 3Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 4Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 2Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 3Health News:Live to 100 ... And Feel Great 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/23/2008)...py to Treat the Disease -, WAYNE, N.J. and EMERYV...yer HealthCare Pharmaceuticals and Onyx Pharmaceut...e New England Journal of Medicine published,result... (sorafenib),tablets decreased the absolute risk o...e hepatocellular carcinoma (HCC), or liver cancer,...
(Date:7/23/2008).../ -- The following was,released by the U.S. Depart...r Smith, and Members of the Committee.,Thank you f...eared before this Committee almost six months ago,...ented and dedicated professionals,at the Justice D...me to,appreciate that much more deeply their servi...
(Date:7/23/2008)...ode BioPharmaceutics, Inc.,an emerging biopharmac...results demonstrating the utility of their lead dr...hronic blood disorder paroxysmal nocturnal,hemoglo...ted at the XXII,International Complement Workshop ...nly treatment currently available for PNH patients...
(Date:7/22/2008)...irstCall/ -- Following a,thorough review that conc...uticals Limited (ASX: PGL; Nasdaq: PGLA) today ann...study in liver cancer. Progen confirmed,its strate... compounds and,the company will actively seek to a...ugh Merger & Acquisition activity., The strategic...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 1Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 2Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 1Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 2Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 3Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 4Varian Announces Global Clinical Council to Develop RapidArc 28TM 29 Cancer Treatments 14693 5National Parkinson Foundation Announces Its New President and CEO 14689 1National Parkinson Foundation Announces Its New President and CEO 14689 2National Parkinson Foundation Announces Its New President and CEO 14689 3Michigan State Medical Society Will Present How VEBA is Shifting Michigans Health Care Gears 14686 1
... -- Additional Findings Reported Safety & Tole...and Healthy Subjects --, CHICAGO, June 25, 2007 /P...his week at the annual meeting of the American Dia...n inhibitor of,dipeptidyl-peptidase-4 (DPP-4) in d...raZeneca , in combination with metformin,exhibite...
... ,Focus On AV411,s Unique Mechanism of Action an...l Conditions , ALAMEDA, Calif., June 26, 2007 (PRI...harmaceutical company innovating therapeutics,for ...d today that,Expert Opinion on Investigational Dru...eline product, AV411 (ibudilast), a potential,firs...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
Our Tri-Flo® suction catheter design was created to be less traumatic to your patients while still providing high suctioning efficiency. Our infant and pediatric catheters (5/6, 8 or 10 Fr) featu
Tracheal Suction Latex Rubber Catheters - Funnel End
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip.
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning.
Medicine Products: